Research
Bath ASU’s full-time research and development laboratory does valuable work to improve the safety and stability of patient-bound products.
Research Blog
-
Student Exam Success…
-
Lecanemab: A New Hope for Alzheimer’s Patients.
-
Is This the End of the “mabs”?
-
R&D Team attend Oncology Pharmacy Symposium
-
R&D Team attend BOPA and NHS QAT Symposia
-
Monoclonal Antibodies to Mitigate Migraine
-
Sirukumab Set to Establish New Field
-
Bath ASU R&D meets Corsham School students
-
Michelle Donelan MP meets Bath ASU research and development team
-
ADC Structure, Safety & Stability, from the 2015 NHS QA Symposium
-
ADCs: Pipeline and Progress
-
ADCs: Origins and Obstacles
-
ADCs: Pros and Cons
-
ADCs: Function & Pharmacology
-
ADCs: What are they and why do they matter?
-
Knowledge Transfer Programme Award
-
Bath ASU BOPA poster amongst “The Best Abstracts Chosen for Plenary”
-
Immune Checkpoint Blockers Deliver Success in Cancer Immunotherapy
-
Do mAbs improve (maybe like a good wine) with age?
-
Biological Drugs – Risk management for sterile preparation in hospital pharmacies
-
Article Review – Long-term stability of bevacizumab repacked in 1 mL polypropylene syringes for intravitreal administration
-
Article Review – Long-term physiochemical stability of diluted trastuzumab
-
Biological Drugs – practical considerations for handling and storage
-
NHS Stability Guidance
-
Article Review – Physiochemical stability of diluted Trastuzumab infusion solutions in polypropylene infusion bags
-
Article Review – Long-term stability of diluted solutions of the monoclonal antibody rituximab
-
Bevacizumab SPC updated – Why?
-
The Chemistry of Monoclonal Antibodies
-
MABs Stability – Analytical Techniques
